EYE INFLAMMATION TREATMENT MARKET ANALYSIS

Market Challenges And Opportunities

Global Eye Inflammation Treatment Market Key Drivers

Increasing research and development by key market players for the development of new eye inflammation treatment is expected to drive the growth of global eye inflammation treatment market over the forecast period.

Market players are involved in research and development for the development of eye inflammation treatment is expected to drive the growth of global eye inflammation treatment market. For instance, on April 21, 2022, SALVAT, a manufacturer of sterile liquids pharmaceutical products, completed the phase III clinical trials of its ocular corticosteroid with clobetasol for the treatment of inflammation and pain in cataract surgery patients. To commercialize the new corticosteroid globally in the second half of 2023, the company has started the approval application processes with the U.S. Food and Drug Administration (FDA) and the European health authorities.

Increasing product launch by key market players, for the treatment of eye disease is expected to propel the growth of global eye inflammation treatment market, over the forecast period.

Key market players are launching product for the treatment of eye disease is expected to propel the growth of global eye infection treatment market. For instance, on January 10, 2022, NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, announced the launch of its AVENOVA Lubricant Eye drops. These eye drops are formulated to treat dry eye symptoms. Avenova is antimicrobial and uses pure 0.01% Hypochlorous Acid that fight with toxins and inflammation caused by bacteria.

Global Eye Inflammation Treatment Market – Restraints

The side effects associated with the use of eye anti-inflammatory drugs is expected to hamper the growth of global eye inflammation treatment market. For instance, according to data published on July 01, 2022, by Mayo Foundation for Medical Education and Research, an academic medical center, eye anti-inflammatory drugs may sometime have side effects such as blurred vision or other change in vision, fever or chills, pain, bleeding in the eye, etc. which can become worse while using drugs. These side effects may stop during the treatment as body adjusts to the drugs or side effects can become worse which needed doctor attention.

Moreover, challenging manufacturing process is also expected to limit the market growth. Eye care product needs unique manufacturing process for making the product appropriately aligned with the GMP regulations for sterile products. Since the formulations are prone to get affected by the pathogens available in the environment, they are formulated under highly protected area.